Interstitial Lung Disease after Crizotinib Treatment in a Patient with ROS-1 Positive Non-Small Cell Lung Cancer

Atıf

Paylaş

Poster Presentation

CİLT: 20 SAYI: 1

P: 261 - 261

Nisan 2019

Interstitial Lung Disease after Crizotinib Treatment in a Patient with ROS-1 Positive Non-Small Cell Lung Cancer

Turk Thorac J 2019;20(1):261-261

DOI: 10.5152/TurkThoracJ.2019.261

1. Department of Chest Diseases, Selçuk University School of Medicine, Konya, Turkey

Bilgi mevcut değil.

Bilgi mevcut değil

Kabul Tarihi: 08.08.2019

Online Tarih: 08.08.2019

Yayın Tarihi: 08.08.2019

Atıf

Paylaş